ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation

March 28, 1986

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

NCI to Fund 122 More Grants in FY04

March 28, 2003